Frankfurt - Delayed Quote EUR
Zimmer Biomet Holdings, Inc. (ZIM.F)
90.02
+1.00
+(1.12%)
As of 8:10:12 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
7,678,600
7,678,600
7,394,200
6,939,900
6,827,300
Cost of Revenue
2,191,200
2,191,200
2,083,800
2,019,500
1,960,400
Gross Profit
5,487,400
5,487,400
5,310,400
4,920,400
4,866,900
Operating Expense
3,959,100
3,959,100
3,859,100
3,728,300
3,861,500
Operating Income
1,528,300
1,528,300
1,451,300
1,192,100
1,005,400
Net Non Operating Interest Income Expense
-218,000
-218,000
-201,200
-164,800
-208,400
Other Income Expense
-273,700
-273,700
-182,900
-623,800
-298,000
Pretax Income
1,036,600
1,036,600
1,067,300
403,500
499,000
Tax Provision
131,400
131,400
42,200
112,300
53,500
Net Income Common Stockholders
903,800
903,800
1,024,000
231,400
401,600
Diluted NI Available to Com Stockholders
903,800
903,800
1,024,000
231,400
401,600
Basic EPS
4.45
4.45
4.91
1.10
1.93
Diluted EPS
4.43
4.43
4.88
1.10
1.91
Basic Average Shares
203,100
203,100
208,700
209,600
208,600
Diluted Average Shares
203,900
203,900
209,700
210,300
210,400
Total Operating Income as Reported
1,285,700
1,285,700
1,277,700
696,300
860,300
Total Expenses
6,150,300
6,150,300
5,942,900
5,747,800
5,821,900
Net Income from Continuing & Discontinued Operation
903,800
903,800
1,024,000
231,400
401,600
Normalized Income
1,115,589.80
1,115,589.80
1,190,656
647,671.80
722,008.60
Interest Expense
218,000
218,000
201,200
164,800
208,400
Net Interest Income
-218,000
-218,000
-201,200
-164,800
-208,400
EBIT
1,254,600
1,254,600
1,268,500
568,300
707,400
EBITDA
2,250,900
2,250,900
2,220,200
1,494,700
1,645,100
Reconciled Cost of Revenue
1,786,800
1,786,800
1,693,600
1,619,900
1,552,200
Reconciled Depreciation
996,300
996,300
951,700
926,400
937,700
Net Income from Continuing Operation Net Minority Interest
903,800
903,800
1,024,000
290,200
445,000
Total Unusual Items Excluding Goodwill
-242,600
-242,600
-173,600
-495,800
-310,200
Total Unusual Items
-242,600
-242,600
-173,600
-495,800
-310,200
Normalized EBITDA
2,493,500
2,493,500
2,393,800
1,990,500
1,955,300
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-30,810.20
-30,810.20
-6,944
-138,328.20
-33,191.40
12/31/2021 - 8/13/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade